CBPO [China Biologic Products] SC 13D/A: (Original Filing)

[Siu Ling Chan 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ ¨ (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS PF 5 ¨ 6 CITIZENSHIP OR PLACE OF ORGANIZATION People’s Republic of China NUMBER OF 7 SOLE VOTING POWER 1 3,012,624 SHARES BENEFICIALLY]

WUBA [58.com] SC 13G: (Original Filing)

[* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed]

CBPO [China Biologic Products] SC 13D/A: Siu Ling Chan 2 CHECK THE APPROPRIATE BOX

[Siu Ling Chan 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ ¨ (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS PF 5 ¨ 6 CITIZENSHIP OR PLACE OF ORGANIZATION People’s Republic of China NUMBER OF 7 SOLE VOTING POWER 1 3,012,624 SHARES BENEFICIALLY]

ISS [iSoftStone] SC 13D/A: (Original Filing)

[Execution Version February 28, 2014 Accurate Global Limited Advanced Orient Limited CSOF Technology Investments Limited c/o China Everbright Investment Management Limited Direct Investment Department 40/F, Far East Finance Centre 16 Harcourt Road Hong Kong Attention: Ip Kun Wan, Kiril Dear Sirs, Framework Agreement ChinaAMC Accurate Advanced CSOF Everbright Entities Agreement Reference is made to the Framework Agreement (the “ Fees] [SCHEDULE 13D CUSIP No 46489B108 Page 2 1 Name of reporting persons CHINA EVERBRIGHT LIMITED 2 Check the appropriate box if a member of a group (see instructions) ¨ x (a) 3 SEC use only 4 Source of funds (see instructions) WC, OO 5 ¨]

CBPO [China Biologic Products] 8-K: (Original Filing)

[CREDIT AGREEMENT Dated as of February 25, 2014 between CHINA BIOLOGIC PRODUCTS, INC. as Borrower, and CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH as Lender TABLE OF CONTENTS Page No. SECTION 1 Definitions 1 1.1 Definitions 1 1.2 Other Definitional Provisions 8 1.3 Computation of Time Periods 8 1.4 Accounting Terms 8 SECTION 2 THE CREDIT FACILITIES 9 2.1] [STANDBY LETTER OF CREDIT DATE OF ISSUE: February 26 , 2014 ADVISING BANK: CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH STANDBY LETTER OF CREDIT REF.: 110LG1400023 DATE OF EXPIRY: February 25, 2016 BENEFICIARY (NAME AND ADDRESS): CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH, NY DEAR SIRS, AT THE REQUEST OF SHANDONG TAIBANG BIOLOGICAL PRODUCTS CO., LTD. (APPLICANT), WE] [STANDBY LETTER OF CREDIT DATE OF ISSUE: February 26, 2014 ADVISING BANK: CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH STANDBY LETTER OF CREDIT REF.: 110LG1400024 DATE OF EXPIRY: August 25 , 2015 BENEFICIARY (NAME AND ADDRESS): CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH, NY DEAR SIRS, AT THE REQUEST OF SHANDONG TAIBANG BIOLOGICAL PRODUCTS CO., LTD. (APPLICANT), WE] [Guarantee Agreement (Applicable to Any Guarantee Provided by Bank) No: 110LG1400023 Agreement This Guarantee Agreement (hereinafter referred to as this “ Principal 1. Shandong Taibang Biological Products Co., Ltd., as the principal (hereinafter referred to as the “ Guarantor 2. China Merchants Bank Co., Ltd., Beijing Shuangyushu Branch, as the guarantor (hereinafter referred to as the “ ¨ Credit Agreement] [Guarantee Agreement (Applicable to Any Guarantee Provided by Bank) No: 110LG1400024 Agreement This Guarantee Agreement (hereinafter referred to as this “ Principal 1. Shandong Taibang Biological Products Co., Ltd., as the principal (hereinafter referred to as the “ Guarantor 2. China Merchants Bank Co., Ltd., Beijing Shuangyushu Branch, as the guarantor (hereinafter referred to as the “ ¨ Credit Agreement] [FOR RELEASE March 3, 2014 China Biologic Completes Stock Repurchase Transaction BEIJING, China – March 3, 2014 – Mr. David (Xiaoying) Gao, Chairman and Chief Executive Officer of China Biologic, commented, “In the past six months, we have closed two share repurchase transactions totaling 3.98 million shares of common stock for a total consideration of $99.6 million. Through these repurchase] []

ISS [iSoftStone] SC 13D/A: Execution Version February 28, 2014 Accurate Global Limited

[Execution Version February 28, 2014 Accurate Global Limited Advanced Orient Limited CSOF Technology Investments Limited c/o China Everbright Investment Management Limited Direct Investment Department 40/F, Far East Finance Centre 16 Harcourt Road Hong Kong Attention: Ip Kun Wan, Kiril Dear Sirs, Framework Agreement ChinaAMC Accurate Advanced CSOF Everbright Entities Agreement Reference is made to the Framework Agreement (the “ Fees] [SCHEDULE 13D CUSIP No 46489B108 Page 2 1 Name of reporting persons CHINA EVERBRIGHT LIMITED 2 Check the appropriate box if a member of a group (see instructions) ¨ x (a) 3 SEC use only 4 Source of funds (see instructions) WC, OO 5 ¨]

CBPO [China Biologic Products] 8-K: CREDIT AGREEMENT Dated as of February 25, 2014

[CREDIT AGREEMENT Dated as of February 25, 2014 between CHINA BIOLOGIC PRODUCTS, INC. as Borrower, and CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH as Lender TABLE OF CONTENTS Page No. SECTION 1 Definitions 1 1.1 Definitions 1 1.2 Other Definitional Provisions 8 1.3 Computation of Time Periods 8 1.4 Accounting Terms 8 SECTION 2 THE CREDIT FACILITIES 9 2.1] [STANDBY LETTER OF CREDIT DATE OF ISSUE: February 26 , 2014 ADVISING BANK: CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH STANDBY LETTER OF CREDIT REF.: 110LG1400023 DATE OF EXPIRY: February 25, 2016 BENEFICIARY (NAME AND ADDRESS): CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH, NY DEAR SIRS, AT THE REQUEST OF SHANDONG TAIBANG BIOLOGICAL PRODUCTS CO., LTD. (APPLICANT), WE] [STANDBY LETTER OF CREDIT DATE OF ISSUE: February 26, 2014 ADVISING BANK: CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH STANDBY LETTER OF CREDIT REF.: 110LG1400024 DATE OF EXPIRY: August 25 , 2015 BENEFICIARY (NAME AND ADDRESS): CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH, NY DEAR SIRS, AT THE REQUEST OF SHANDONG TAIBANG BIOLOGICAL PRODUCTS CO., LTD. (APPLICANT), WE] [Guarantee Agreement (Applicable to Any Guarantee Provided by Bank) No: 110LG1400023 Agreement This Guarantee Agreement (hereinafter referred to as this “ Principal 1. Shandong Taibang Biological Products Co., Ltd., as the principal (hereinafter referred to as the “ Guarantor 2. China Merchants Bank Co., Ltd., Beijing Shuangyushu Branch, as the guarantor (hereinafter referred to as the “ ¨ Credit Agreement] [Guarantee Agreement (Applicable to Any Guarantee Provided by Bank) No: 110LG1400024 Agreement This Guarantee Agreement (hereinafter referred to as this “ Principal 1. Shandong Taibang Biological Products Co., Ltd., as the principal (hereinafter referred to as the “ Guarantor 2. China Merchants Bank Co., Ltd., Beijing Shuangyushu Branch, as the guarantor (hereinafter referred to as the “ ¨ Credit Agreement] [FOR RELEASE March 3, 2014 China Biologic Completes Stock Repurchase Transaction BEIJING, China – March 3, 2014 – Mr. David (Xiaoying) Gao, Chairman and Chief Executive Officer of China Biologic, commented, “In the past six months, we have closed two share repurchase transactions totaling 3.98 million shares of common stock for a total consideration of $99.6 million. Through these repurchase] []

ISS [iSoftStone] SC 13D/A: (Original Filing)

[February 28, 2014 Mr. Tianwen Liu Building 16, Dong Qu 10 Xibeiwang Dong Lu Haidian District Beijing 100193 P. R. China Dear Mr. Liu, Consortium Agreement ChinaAMC Agreement Reference is made to the Consortium Agreement (the “ Fees and Expenses 2. Each party hereto acknowledges and agrees that ChinaAMC and Mr. Tianwen Liu shall each be responsible for 30.00% and] [CONSORTIUM AGREEMENT Agreement Founder Accurate Advanced CSOF Existing Shareholders Consortium Members Consortium Member THIS CONSORTIUM AGREEMENT (this “ RECITALS Consortium Transaction Company NYSE Exchange Act WHEREAS, the Consortium Members propose to form a consortium (the “ Parent Merger Sub WHEREAS, (a) in connection with the Transaction, the Consortium Members propose to form a new company (“ Company Board Merger Agreement] [46489B108 CUSIP No. Page 2 of 6 Pages 1. Names of reporting persons Tianwen Liu 2. Check the appropriate box if a member of a group ¨ x (a) 3. SEC use only]

Skip to toolbar